Cargando…
The Traditional Japanese Herbal Medicine Hachimijiogan Elicits Neurite Outgrowth Effects in PC12 Cells and Improves Cognitive in AD Model Rats via Phosphorylation of CREB
Hachimijiogan (HJG) is a traditional herbal medicine that improves anxiety disorders in patients with dementia. In this study, we tested the hypothesis that HJG exerts neurotrophic factor-like effects to ameliorate memory impairment in Alzheimer disease (AD) model rats. First, we describe that HJG a...
Autores principales: | Kubota, Kaori, Fukue, Haruka, Sato, Hitomi, Hashimoto, Kana, Fujikane, Aya, Moriyama, Hiroshi, Watanabe, Takuya, Katsurabayashi, Shutaro, Kainuma, Mosaburo, Iwasaki, Katsunori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702328/ https://www.ncbi.nlm.nih.gov/pubmed/29209220 http://dx.doi.org/10.3389/fphar.2017.00850 |
Ejemplares similares
-
Neurite outgrowth in peripherin-depleted PC12 cells
Publicado: (1992) -
The efficacy and safety of hachimijiogan for mild Alzheimer disease in an exploratory, open standard treatment controlled, randomized allocation, multicenter trial: A study protocol
por: Kainuma, Mosaburo, et al.
Publicado: (2020) -
Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation
por: Funakoshi-Tago, Megumi, et al.
Publicado: (2020) -
Metabolic changes in the plasma of mild Alzheimer’s disease patients treated with Hachimijiogan
por: Kainuma, Mosaburo, et al.
Publicado: (2023) -
An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease
por: Kainuma, Mosaburo, et al.
Publicado: (2022)